SHA/688506 (SHA/688506)

Shanghai Stock Exchange: SHA/688506 · CNY

CN¥238

-8.68 (-3.5%)· Recorded snapshot

Market cap	98.4B
Revenue (ttm)	2.5B
Net income (ttm)	-1.6B
EPS (ttm)	-CN¥3.84
Shares out	412.9M
Volume	1,774,878
Beta	-0.05

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.5B
Net income (ttm): -1.6B
EPS (ttm): -CN¥3.84
Market cap: 98.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-42.5

P25 n/aP50 n/aP75 n/a

ROIC-42.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SHA/688506 indicators

Market & fundamental data

Available fields

176

Groups with data

Currency

CNY

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CNY
Country	China
Country code	CN
Earnings date	2026-10-31
Employees	3,434
Employees change	236
Employees growth	7.38%
Enterprise value	CNY 94.7B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1996
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CNE100006FN4
Last earnings date	2026-08-27
Last refreshed	2026-10-28
Market cap	CNY 98.4B
Next earnings date	2026-10-31
Price	CNY 238.32
Price currency	CNY
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	sha/688506
Website	https://www.baili-pharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-1.61%
EV/Sales	37.33x
FCF / EV yield	-1.68%
FCF yield	-1.61%
Industry forward P/E	18.72x
Industry P/E	33.27x
P/B ratio	21.34x
P/S ratio	38.8x
Price / tangible book value	21.48x
Sector forward P/E	20.65x
Sector P/E	37.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-48.6%
EBITDA margin	-45.07%
Gross margin	89.67%
Operating margin	-48.6%
Pretax margin	-50.12%
Profit margin	-62.02%
Profit per employee	CNY -458,032
Revenue per employee	CNY 738,570
ROA	-8.45%
ROA (5Y)	-0.87%
ROCE	-14.11%
ROE	-42.46%
ROE (5Y)	-10.06%
ROIC	-42.36%
Tax / revenue	11.9%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	1,174.87%
Gross profit growth (Q)	-12.6%
Gross profit growth 3Y	72.58%
Gross profit growth 5Y	53.13%
Revenue growth	474.87%
Revenue growth (Q)	-10.61%
Revenue growth (QoQ)	-1.94%
Revenue growth 3Y	52.9%
Revenue growth 5Y	43.63%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CNY -387.7M
Depreciation and amortization	CNY 89.4M
EBIT	CNY -1.2B
EBITDA	CNY -1.1B
EPS	CNY -3.84
FCF per share	CNY -3.85
Financing cash flow	CNY 5.2B
Free cash flow	CNY -1.6B
Gross profit	CNY 2.3B
Income taxes	CNY 301.8M
Investing cash flow	CNY -3.4B
Net borrowing	CNY 2B
Net cash flow	CNY 254.4M
Net income	CNY -1.6B
Operating income	CNY -1.2B
Revenue	CNY 2.5B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	12.45
Book value per share	CNY 11.17
Debt / equity	1.14
Interest coverage	-11.6
Long-term assets	CNY 1.2B
Long-term liabilities	CNY 4.1B
Net cash (debt)	CNY 3.7B
Net cash / market cap	3.79%
Net cash growth	55.84%
Net debt / equity	-0.81
Piotroski F-Score	4
Property, plant and equipment	CNY 969.8M
Shareholders' equity	CNY 4.6B
Tangible book value	CNY 4.6B
Tangible book value per share	CNY 11.10
Total assets	CNY 11.1B
Total cash	CNY 9B
Total debt	CNY 5.2B
Total liabilities	CNY 6.4B
WACC	3.87%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.28
Current assets	CNY 9.8B
Current liabilities	CNY 2.3B
Current ratio	4.23
Inventory turnover	1.5
Net working capital	CNY -198.4M
Quick ratio	3.9
Working capital	CNY 7.5B
Working capital turnover	0.42

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.2%
Shareholder yield	-2.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CNY 271.29
1D price change	-3.51%
1M price change	3.22%
1M total return	3.22%
1W price change	-2.02%
1W total return	-2.02%
1Y price change	-30.23%
1Y return CAGR	-30.24%
1Y total return	-30.23%
20-day SMA	CNY 240.52
200-day SMA	CNY 276.34
3M price change	-21.14%
3M total return	-21.14%
3Y price change	187.21%
3Y return CAGR	42.13%
3Y total return	187.21%
50-day SMA	CNY 256.36
50-day SMA vs 200-day SMA	50under200
52-week high	CNY 404.00
52-week high date	2025-11-25
52-week low	CNY 200.10
52-week low date	2026-06-02
6M price change	-13.19%
6M total return	-13.19%
All-time high	CNY 414.02
All-time high date	2025-09-08
All-time low	CNY 28.75
All-time low date	2023-01-06
Average true range (ATR)	CNY 13.38
Average volume	1.6M
Beta (1Y)	-0.47
Beta (2Y)	-0.26
Beta (5Y)	-0.05
Change from 52-week high	-41.01%
Change from 52-week low	19.1%
Change from all-time high	-40.34%
Change from all-time low	759.13%
Change from open	-3.31%
Day's gap	-0.21%
Dollar volume	CNY 423M
High price	CNY 250.58
Low price	CNY 235.17
Monthly RSI	47.46
Open price	CNY 246.48
Position in 52-week range	20.44%
Previous close	CNY 247.00
Price vs 150-day SMA	-8.95%
Price vs 20-day SMA	2.7%
Price vs 200-day SMA	-10.62%
Price vs 50-day SMA	-3.65%
Relative volume	1.05
RSI	44.88
Sharpe ratio	-0.44
Sharpe ratio (3Y)	0.81
Sortino ratio	-0.59
Sortino ratio (3Y)	1.54
Volume	1.8M
Weekly RSI	42.59
YTD price change	-23.55%
YTD total return	-23.55%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	79.1M
Shares change (QoQ)	0.19%
Shares change (YoY)	2.2%
Shares held by insiders	74.6%
Shares held by institutions	11.22%
Shares outstanding	412.9M

Deeper analysis on SHA/688506

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SHA/688506 report

Is a complete SHA/688506 research report available?

No complete published report is available for sha/688506 (SHA/688506) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SHA/688506 (SHA/688506)

Price

Financial snapshot

Fair-value bridge

Latest news · SHA/688506

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHA/688506 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SHA/688506

Frequently asked questions